- Microsoft Word
- Western Blot
- Microsoft Powerpoint
- Molecular Biology
We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.
Research summer interns will be assigned high visibility projects that align with Atara’s key scientific objectives in a dynamic and exciting cell therapy start-up biotech environment. Projects may include but are not limited to supporting functional areas such as Pre-Clinical and Translational Sciences. Interns will have the ability to work cross-functionally, meet with key executives, and be coached by some of the best scientific leaders in the industry. Interns will also be assigned a mentor, attend executive lunch and learns, attend great company culture events, and conclude their summer with a scientific presentation of their work.
Reports to: Principal Scientist
Location: Thousand Oaks, CA (Northwest Los Angeles)
Pursuing graduate degree, majoring in pharmacology, cell biology, immunology or related discipline
Must be 18 years or older
3.2 GPA and above, with recommendation available from laboratory and major curriculum instructors or academic department head
Must have completed at least 1 full year of graduate-level study by summer 2019
Must not have already graduated by summer 2019
Familiarity with molecular biology and/or cellular biology bench techniques (PCR, Western blot, cell culture, etc.)
Must have the ability to get work authorization
Excellent analytical, interpersonal, verbal and written communication skills.
Proficient in MS Word, Excel, Power Point.
General understanding of biological and cellular processes that contribute to therapeutic potential
Self-motivated, flexible and creative, able to prioritize, multi-task, and work in a fast-paced and demanding environment.
Must be a self-starter, collaborates cross-functionally, and can work independently with minimal functional oversight.
Effective interpersonal skills as a team player.
Subject to extended periods of sitting and/or standing, vision to monitor and moderate noise levels. Work is generally performed in a laboratory or office environment.
More About Atara Bio
Now in our sixth year, we’re proud of our team of 200+ Atarians co-located co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.
One mission - Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise – and a singular vision - Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.
The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.
Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).
Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV).
Working at Atara Bio
People at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.
Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.
We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States.